tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Benjamin Burnett, 202 are a BUY (72.4%), 77 are a HOLD (27.6%).
Analyst Benjamin Burnett, currently employed at WELLS FARGO, carries an average stock price target met ratio of 47.35% that have a potential upside of 36.34% achieved within 133 days.
Benjamin Burnett’s has documented 527 price targets and ratings displayed on 44 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on PTCT, PTC Therapeutics at 20-Jul-2026.
Analyst best performing recommendations are on EFTR (EFFECTOR THERAPEUTICS).
The best stock recommendation documented was for CRSP (CRISPR THERAPEUTICS AG) at 2/13/2025. The price target of $49 was fulfilled within 1 day with a profit of $5.51 (12.67%) receiving and performance score of 126.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Apr-2023
$11
$8.87 (416.43%)
$12
3 months 12 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Hold Since 21-Mar-2023
$3.85
$1.72 (80.75%)
$2.5
3 months 14 days ago
(14-Apr-2026)
2/3 (66.67%)
$1.13 (41.54%)
155
Buy Since 14-May-2025
$9
$6.87 (322.54%)
$9
3 months 14 days ago
(14-Apr-2026)
1/4 (25%)
$6.28 (230.88%)
19
Buy Since 05-Nov-2018
$8
$5.87 (275.59%)
4 months 15 days ago
(13-Mar-2026)
2/7 (28.57%)
$5.6 (233.33%)
3
Buy Since 04-Nov-2019
4 months 16 days ago
(13-Mar-2026)
1/2 (50%)
$28.66 (452.05%)
192
Which stock is Benjamin Burnett is most bullish on?
Which stock is Benjamin Burnett is most reserved on?
What Year was the first public recommendation made by Benjamin Burnett?
